Exposure–Response‐Based Product Profile–Driven Clinical Utility Index for Ipatasertib Dose Selection in Prostate Cancer

Rui Zhu; Bill Poland; Russ Wada; Qi Liu; Luna Musib; Daniel Maslyar; Eunpi Cho; Wei Yu; Han Ma; Jin Yan Jin; Nageshwar Budha

doi:10.1002/psp4.12394

Exposure–Response‐Based Product Profile–Driven Clinical Utility Index for Ipatasertib Dose Selection in Prostate Cancer

CPT Pharmacometrics & Systems Pharmacology ◽

10.1002/psp4.12394 ◽

2019 ◽

Vol 8 (4) ◽

pp. 240-248 ◽

Cited By ~ 3

Author(s):

Rui Zhu ◽

Bill Poland ◽

Russ Wada ◽

Qi Liu ◽

Luna Musib ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Utility ◽

Dose Selection ◽

Exposure Response ◽

Utility Index ◽

Product Profile

Download Full-text

A Personalized Medicine Approach Using Clinical Utility Index and Exposure‐Response Modeling Informed by Patient Preferences Data

CPT Pharmacometrics & Systems Pharmacology ◽

10.1002/psp4.12570 ◽

2020 ◽

Author(s):

Insa Winzenborg ◽

Ahmed M. Soliman ◽

Mohamad Shebley

Keyword(s):

Personalized Medicine ◽

Patient Preferences ◽

Clinical Utility ◽

Exposure Response ◽

Utility Index ◽

Response Modeling

Download Full-text

Edoxaban Exposure‐Response Analysis and Clinical Utility Index Assessment in Patients With Symptomatic Deep‐Vein Thrombosis or Pulmonary Embolism

CPT Pharmacometrics & Systems Pharmacology ◽

10.1002/psp4.12077 ◽

2016 ◽

Vol 5 (4) ◽

pp. 222-232 ◽

Cited By ~ 5

Author(s):

J Nyberg ◽

KE Karlsson ◽

S Jönsson ◽

OQP Yin ◽

R Miller ◽

...

Keyword(s):

Pulmonary Embolism ◽

Deep Vein Thrombosis ◽

Clinical Utility ◽

Response Analysis ◽

Symptomatic Deep Vein Thrombosis ◽

Vein Thrombosis ◽

Exposure Response ◽

Utility Index ◽

Deep Vein

Download Full-text

P48.23 Exposure-Response Analyses and Clinical Utility Index to Justify the Dosage of Lurbinectedin in Small-cell Lung Cancer

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2021.01.893 ◽

2021 ◽

Vol 16 (3) ◽

pp. S509

Author(s):

C. Fernandez Teruel ◽

R. Lubomirov ◽

S. Fudio

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Clinical Utility ◽

Small Cell ◽

Small Cell Lung ◽

Exposure Response ◽

Utility Index

Download Full-text

Faculty Opinions recommendation of Clinical utility of an epigenetic assay to detect occult prostate cancer in histopathologically negative biopsies: results of the MATLOC study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717983384.793479430 ◽

2013 ◽

Author(s):

Hendrik van Poppel ◽

Yuri Tolkach

Keyword(s):

Prostate Cancer ◽

Clinical Utility ◽

Negative Biopsies

Download Full-text

The Clinical Utility of 18F-Fluciclovine PET/CT in Biochemically Recurrent Prostate Cancer: an Academic Center Experience Post FDA Approval

Molecular Imaging and Biology ◽

10.1007/s11307-021-01583-3 ◽

2021 ◽

Author(s):

Ryusuke Nakamoto ◽

Caitlyn Harrison ◽

Hong Song ◽

Kip E. Guja ◽

Negin Hatami ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Utility ◽

Recurrent Prostate Cancer ◽

Academic Center ◽

Fda Approval ◽

Pet Ct

Download Full-text

The Clinical Utility of Measuring Total PSA, PSA Density, gamma-Seminoprotein and gamma-Seminoprotein/Total PSA in Prostate Cancer Prediction

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyd089 ◽

2000 ◽

Vol 30 (8) ◽

pp. 337-342 ◽

Cited By ~ 4

Author(s):

R. Sasaki

Keyword(s):

Prostate Cancer ◽

Clinical Utility ◽

Cancer Prediction ◽

Psa Density ◽

Total Psa

Download Full-text

Exposure–Response Analyses for Therapeutic Dose Selection of Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma

Clinical Pharmacology & Therapeutics ◽

10.1002/cpt.2409 ◽

2021 ◽

Author(s):

Geraldine Ferron‐Brady ◽

Chetan Rathi ◽

Jon Collins ◽

Herbert Struemper ◽

Joanna Opalinska ◽

...

Keyword(s):

Multiple Myeloma ◽

Therapeutic Dose ◽

Dose Selection ◽

Refractory Multiple Myeloma ◽

Exposure Response ◽

Selection Of

Download Full-text

Prostate-specific Membrane Antigen Theranostics for Prostate Cancer Care: A Need to Prove Clinical Utility

European Urology Focus ◽

10.1016/j.euf.2021.01.009 ◽

2021 ◽

Author(s):

Alec Paschalis ◽

Bertrand Tombal ◽

Johann S. de Bono

Keyword(s):

Prostate Cancer ◽

Cancer Care ◽

Clinical Utility ◽

Prostate Specific Membrane Antigen ◽

Specific Membrane

Download Full-text

Exposure–response relationship of AMG 386 in combination with weekly paclitaxel in recurrent ovarian cancer and its implication for dose selection

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-011-1787-5 ◽

2012 ◽

Vol 69 (5) ◽

pp. 1135-1144 ◽

Cited By ~ 28

Author(s):

Jian-Feng Lu ◽

Erik Rasmussen ◽

Beth Y. Karlan ◽

Ignace B. Vergote ◽

Lynn Navale ◽

...

Keyword(s):

Ovarian Cancer ◽

Recurrent Ovarian Cancer ◽

Weekly Paclitaxel ◽

Response Relationship ◽

Dose Selection ◽

Exposure Response ◽

Amg 386 ◽

Relationship Of

Download Full-text

Clinical utility of apparent diffusion coefficient (ADC) values in patients with prostate cancer: Can ADC values contribute to assess the aggressiveness of prostate cancer?

Journal of Magnetic Resonance Imaging ◽

10.1002/jmri.22317 ◽

2010 ◽

Vol 33 (1) ◽

pp. 167-172 ◽

Cited By ~ 89

Author(s):

Yasushi Itou ◽

Katsuyuki Nakanishi ◽

Yoshifumi Narumi ◽

Yasuko Nishizawa ◽

Hideaki Tsukuma

Keyword(s):

Prostate Cancer ◽

Diffusion Coefficient ◽

Apparent Diffusion Coefficient ◽

Clinical Utility ◽

Apparent Diffusion ◽

Adc Values

Download Full-text